Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
1.710
-0.020 (-1.16%)
At close: Aug 14, 2025, 4:00 PM
1.720
+0.010 (0.58%)
After-hours: Aug 14, 2025, 7:40 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $272.06 million as of August 14, 2025. Its market cap has decreased by -56.92% in one year.
Market Cap
272.06M
Enterprise Value
212.55M
1-Year Change
-56.92%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has increased from $124.83M to $272.06M, an increase of 117.94%. That is a compound annual growth rate of 13.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 275.07M | -49.26% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | 241.63M | 276.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |